ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia

Clinical trial NCT07420959 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07420959
Sponsor: Mayo Clinic
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Waldenstrom Macroglobulinemia Refractory Waldenstrom Macroglobulinemia

Start date: 2026-10-25
Primary completion: 2036-10-25
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.